Pod Save America - Ezra Klein and Derek Thompson on How Democrats Can Build Their Way Back to Power

In their new book, Abundance, journalists Ezra Klein and Derek Thompson argue that Trump's scarcity mindset is suffocating the country: America doesn’t do enough manufacturing? Better cut back on trade. Not enough jobs or housing? Get rid of immigrants.Klein and Thompson sit down with Jon to explain how faster (and better) infrastructure projects can re-engage Democrats’ base, why tolerating government failure has made liberals look bad, and whether the accusations of neoliberalism that have been levied at the book are a fair criticism of the "abundance agenda."

 

For a closed-captioned version of this episode, click here. For a transcript of this episode, please email transcripts@crooked.com and include the name of the podcast.

Up First from NPR - Gambling with Memes

What do Moo Deng the pygmy hippo, social media sensation Hawk Tuah, and the President of the United States all have in common? They've all inspired highly valuable, highly volatile memecoins. The memecoin began as a sort of joke cryptocurrency, but it soon became very real.

On today's episode of The Sunday Story, we turn to our friends at NPR's Planet Money to help us understand the phenomenon of memecoins. What are they, and how did they go from a one-off joke to a speculative frenzy worth tens of billions of dollars? Who are the winners and losers in this brazen new market?

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

What Next - What Next | Daily News and Analysis – TBD | This Is Your Brain On Ketamine

Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?


Guest: Shayla Love, staff writer for the Atlantic.


Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.


Hosted on Acast. See acast.com/privacy for more information.

What Next - What Next: TBD | Tech, power, and the future – This Is Your Brain On Ketamine

Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?


Guest: Shayla Love, staff writer for the Atlantic.


Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.


Hosted on Acast. See acast.com/privacy for more information.

What Next | Daily News and Analysis - TBD | This Is Your Brain On Ketamine

Ketamine has gone from a recreational psychedelic to an approved treatment, and it has caught on in Silicon Valley in a big way. Are the long-term effects of using ketamine—recreationally or therapeutically—sufficiently known? Are we witnessing them right now?


Guest: Shayla Love, staff writer for the Atlantic.


Want more What Next TBD? Subscribe to Slate Plus to access ad-free listening to the whole What Next family and all your favorite Slate podcasts. Subscribe today on Apple Podcasts by clicking “Try Free” at the top of our show page. Sign up now at slate.com/whatnextplus to get access wherever you listen.

Learn more about your ad choices. Visit megaphone.fm/adchoices

It Could Happen Here - CZM Book Club: Escape, part one

Margaret reads an anonymously authored speculative fiction story about what people could do if large scale roundups began, and discusses it with an anarchist technology enthusiast.

See omnystudio.com/listener for privacy information.

array(3) { [0]=> string(150) "https://www.omnycontent.com/d/programs/e73c998e-6e60-432f-8610-ae210140c5b1/78d30acb-8463-4c40-a5ae-ae2d0145c9ff/image.jpg?t=1749835422&size=Large" [1]=> string(10) "image/jpeg" [2]=> int(0) }

Motley Fool Money - Right Trend, Wrong Stock

Investors weren’t exactly wrong to be excited about the companies trying to make meal kits and plant-based meat cool. But they sure haven’t made any money from those bets. So … what went wrong?


Patrick Badolato is an Associate Professor of Instruction at the McCoombs School of Business at the University of Texas at Austin, where he teaches Accounting. He joins Ricky Mulvey for a conversation about companies that have opened the door for genuinely exciting opportunities, but haven’t yet been able to figure out a workable business model. They also discuss:

Expanding your definition of competition.

Why Blue Apron and Beyond Meat haven’t taken off like their IPO investors hoped.

Whether Coca-Cola is at risk of becoming a “Cabbage Patch concept.”


Companies/tickers discussed: KR, ACI, BYND, MCD, KO, NVDA, CELH, PEP, YETI


Host: Ricky Mulvey

Guest: Patrick Badolato

Producer: Mary Long

Engineer: Dan Boyd, Rick Engdahl

Learn more about your ad choices. Visit megaphone.fm/adchoices

The Gist - Mike on The Mark Reardon Show

Today on The Gist. We play Mikes appearance on The Mark Reardon Show and play an interview from 2022 with Rafael A. Mangual on Depolicing.


Produced by Corey Wara

Email us at thegist@mikepesca.com

To advertise on the show, contact sales@advertisecast.com or visit https://advertising.libsyn.com/TheGist

Subscribe to The Gist: https://subscribe.mikepesca.com/

Subscribe to The Gist Youtube Page: https://www.youtube.com/channel/UC4_bh0wHgk2YfpKf4rg40_g

Subscribe to The Gist Instagram Page: GIST INSTAGRAM

Follow Mikes Substack at: Pesca Profundities | Mike Pesca | Substack

Learn more about your ad choices. Visit podcastchoices.com/adchoices